FX.co ★ Australian Stocks Drop as Tariff Concerns Mount

The S&P/ASX 200 index decreased by nearly 1% to approximately 8,660 on Friday, continuing its decline from the previous session and marking its second consecutive weekly downturn. This slump was exacerbated by increasing uncertainties surrounding U.S. tariffs, as President Trump adjusted "reciprocal" duties on various nations, escalating them to a range of 10–41%. Countries not explicitly listed will automatically incur a 10% levy, while goods that are transshipped will face an additional 40% surcharge, set to be implemented seven days following the announcement. Fortunately for Australia, the anticipated higher tariffs were averted, maintaining a 10% rate despite earlier threats of an increase to 15–20%. The White House attributed this decision to advancements in trade and security discussions, highlighting Australia's progress in nearing agreements with the U.S. Despite this, Australia still experienced a negative market sentiment, contributing to the ASX's decline. Notably, healthcare stocks suffered losses, with biotechnology leader CSL dropping 1.7%. The financial sector also saw a 1.3% decline, with the Big Four banks experiencing reductions exceeding 1.5%. Investors are now looking ahead to the release of the quarterly Producer Price Index (PPI) reports later today.